drugset / Trial / NCT05008887

Fractional CO2 Laser-assisted Cutaneous Delivery of Methotrexate Versus 5-fluorouracil in Stable Non-segmental Vitiligo

NCT05008887

Phase 4 Unknown 50 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

Vitiligo is a common acquired, depigmenting skin disease that affect the patient's psychological state and quality of life.

Timeline

Start
2022-09
Primary completion
2023-03
Completion
2023-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Methotrexate Small molecule 2.5 % Topical
Comparator fluorouracil Small molecule 5 % Topical

Indications